Correlation Between Fennec Pharmaceuticals and Senti Biosciences
Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fennec Pharmaceuticals and Senti Biosciences, you can compare the effects of market volatilities on Fennec Pharmaceuticals and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and Senti Biosciences.
Diversification Opportunities for Fennec Pharmaceuticals and Senti Biosciences
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Fennec and Senti is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and Senti Biosciences go up and down completely randomly.
Pair Corralation between Fennec Pharmaceuticals and Senti Biosciences
Given the investment horizon of 90 days Fennec Pharmaceuticals is expected to under-perform the Senti Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Fennec Pharmaceuticals is 2.37 times less risky than Senti Biosciences. The stock trades about -0.01 of its potential returns per unit of risk. The Senti Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 292.00 in Senti Biosciences on September 1, 2024 and sell it today you would lose (76.00) from holding Senti Biosciences or give up 26.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Fennec Pharmaceuticals vs. Senti Biosciences
Performance |
| Timeline |
| Fennec Pharmaceuticals |
| Senti Biosciences |
Fennec Pharmaceuticals and Senti Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fennec Pharmaceuticals and Senti Biosciences
The main advantage of trading using opposite Fennec Pharmaceuticals and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.| Fennec Pharmaceuticals vs. Molecular Partners AG | Fennec Pharmaceuticals vs. MediciNova | Fennec Pharmaceuticals vs. Anebulo Pharmaceuticals | Fennec Pharmaceuticals vs. Champions Oncology |
| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |